Prognosis
A Blood Test Can Predict Dementia. Trouble Is, There's No Cure
- Roche, Quanterix join Shimadzu in advancing predictive tests
- Diagnostics and drugs market to reach $11.1 billion in 2024
This article is for subscribers only.
Want more news about the future of health care? Sign up here for Bloomberg’s Prognosis newsletter to get great stories delivered to your inbox every Thursday.
Nobel prizewinner Koichi Tanaka says the predictive blood test for Alzheimer’s disease he and colleagues spent almost a decade developing is a double-edged sword.